Haixiang Pharmaceutical announced that Zhejiang Haixiang Chuannan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for cyclophosphoric adenosine approved and issued by the State Drug Administration. The packaging specification is 4 kg/barrel, and the approval conclusion is approval for registration; the API still needs to pass the GMP compliance check before it can be produced and sold domestically.

Haixiang Pharmaceutical announced that Zhejiang Haixiang Chuannan Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for cyclophosphoric adenosine approved and issued by the State Drug Administration. The packaging specification is 4 kg/barrel, and the approval conclusion is approval for registration; the API still needs to pass the GMP compliance check before it can be produced and sold domestically.